IRIS
DOTTA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.675
EU - Europa 15.485
AS - Asia 9.090
SA - Sud America 1.479
AF - Africa 573
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 18
Totale 49.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.452
GB - Regno Unito 3.277
CN - Cina 3.152
SG - Singapore 2.887
RU - Federazione Russa 2.848
IT - Italia 2.254
IE - Irlanda 2.048
UA - Ucraina 1.257
BR - Brasile 1.241
SE - Svezia 992
FR - Francia 882
HK - Hong Kong 822
VN - Vietnam 798
DE - Germania 733
FI - Finlandia 507
KR - Corea 484
ZA - Sudafrica 330
IN - India 254
ES - Italia 173
NL - Olanda 110
CA - Canada 102
TR - Turchia 96
BD - Bangladesh 93
NG - Nigeria 84
BE - Belgio 79
MX - Messico 74
AR - Argentina 72
IQ - Iraq 67
JP - Giappone 65
PK - Pakistan 64
PL - Polonia 54
AT - Austria 53
AU - Australia 46
SA - Arabia Saudita 44
ID - Indonesia 40
CI - Costa d'Avorio 39
EC - Ecuador 36
IR - Iran 33
CO - Colombia 30
CL - Cile 29
CZ - Repubblica Ceca 27
JO - Giordania 26
KE - Kenya 24
MA - Marocco 23
VE - Venezuela 23
EG - Egitto 22
CH - Svizzera 21
GR - Grecia 21
LT - Lituania 21
PE - Perù 19
AE - Emirati Arabi Uniti 18
IL - Israele 17
HU - Ungheria 16
PT - Portogallo 16
RO - Romania 16
DK - Danimarca 15
MY - Malesia 15
UZ - Uzbekistan 15
PY - Paraguay 14
DZ - Algeria 13
EU - Europa 12
PH - Filippine 12
NP - Nepal 11
BY - Bielorussia 10
ET - Etiopia 9
JM - Giamaica 9
AL - Albania 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
TH - Thailandia 8
TN - Tunisia 7
AZ - Azerbaigian 6
BB - Barbados 6
BO - Bolivia 6
CR - Costa Rica 6
EE - Estonia 6
KZ - Kazakistan 6
OM - Oman 6
UY - Uruguay 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
LB - Libano 5
LU - Lussemburgo 5
MD - Moldavia 5
SN - Senegal 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
XK - ???statistics.table.value.countryCode.XK??? 5
BG - Bulgaria 4
KW - Kuwait 4
LV - Lettonia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
BN - Brunei Darussalam 3
CY - Cipro 3
IM - Isola di Man 3
MU - Mauritius 3
PR - Porto Rico 3
Totale 49.322
Salva come PNG Salva come JPEG
Città #
Dallas 3.127
Southend 2.888
Fairfield 2.662
Dublin 2.029
Ashburn 1.657
Houston 1.615
Singapore 1.468
Chandler 1.256
Woodbridge 1.186
Jacksonville 998
Seattle 994
Wilmington 944
Cambridge 901
Moscow 792
Hong Kong 787
Beijing 737
Santa Clara 673
Hefei 573
Ann Arbor 547
San Jose 503
Siena 475
Seoul 457
Princeton 455
The Dalles 364
Nanjing 355
Johannesburg 311
Council Bluffs 295
Helsinki 255
Lauterbourg 250
Los Angeles 248
Florence 239
New York 236
Ho Chi Minh City 214
Hanoi 187
Milan 179
Boardman 170
San Diego 143
Munich 137
San Mateo 132
Nanchang 124
Málaga 122
Buffalo 112
São Paulo 112
Rome 108
Dong Ket 99
Shanghai 99
Columbus 96
Abuja 80
London 73
Redondo Beach 70
Changsha 69
Shenyang 67
Atlanta 59
Tianjin 59
Bengaluru 56
Hebei 54
Orem 53
Dearborn 51
Jiaxing 49
Kunming 48
Frankfurt am Main 47
Tokyo 47
Chicago 45
Nuremberg 45
Zhengzhou 45
Warsaw 44
Brussels 40
San Francisco 40
Abidjan 39
Chennai 38
Falls Church 38
Rio de Janeiro 38
Toronto 38
Norwalk 37
Turku 37
Guangzhou 35
Da Nang 34
Phoenix 32
Brooklyn 31
Montreal 31
Washington 31
Amsterdam 30
Düsseldorf 30
Belo Horizonte 29
Vienna 29
Fremont 28
Brasília 27
Izmir 27
Lappeenranta 27
Leuven 27
Amman 26
Baghdad 25
Jinan 25
Ningbo 25
Hangzhou 24
Lahore 24
Stockholm 24
Dhaka 23
Haiphong 23
Mumbai 22
Totale 34.406
Salva come PNG Salva come JPEG
Nome #
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cells 1.232
Markers of beta cell function in type 1 diabetes mellitus 627
Urban diabetes: The case of the metropolitan area of Rome 445
null 398
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 322
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. 319
Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options 305
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 304
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 303
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 301
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 297
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 293
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 293
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 291
Lymphocyte-derived exosomal microRNAs promote pancreatic β-cell death and may contribute to type 1 diabetes development. 287
Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p 280
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes 279
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 278
Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives 278
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 278
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 275
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 268
MicroRNA expression analysis of in vitro dedifferentiated human pancreatic islet cells reveals the activation of the pluripotency-related microRNA cluster miR-302s 266
Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients. 262
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 261
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 254
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 253
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 251
Putative endothelial progenitor cells predict long-term mortality in type-2 diabetes 250
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 247
Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 245
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 245
Prognostic bioindicators in severe COVID-19 patients 244
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes 240
HbA1c Variability As an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 240
Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis 238
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 237
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 237
Delta-cell specific expression of Hedgehog pathway Ptch1 receptor in murine and human endocrine pancreas 236
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 235
MicroRNAs: markers of β-cell stress and autoimmunity 235
Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus 233
An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment 233
Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy 232
A new solid-phase radioimmunoassay to detect anti-GAD65 autoantibodies 229
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 229
Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects 228
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 225
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 224
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic bh3-only proteins DP5 and PUMA in human pancreatic β-cells 223
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes 221
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 221
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 219
T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus. 217
A prozone phenomenon interferes in islet cell antibody detection: direct comparison of two methods in subjects at risk of diabetes and in insulin dependent diabetics at onset. 217
The Landscape of microRNAs in βCell: between phenotype maintenance and protection 217
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 217
Endocrine actions of osteocalcin 216
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion 214
Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients 213
A novel neuroendocrine cell surface glycoprotein: identification, isolation, and initial characterization 213
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II 211
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 210
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 209
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 209
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial 208
Coxsackieviruses and Insulitis 206
Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humans 204
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study 203
Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. 202
A three-layer perspective on miRNA regulation in β cell inflammation 201
Guidelines for the treatment and management of new-onset diabetes after transplantation 201
12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes Patients 200
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside 200
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells 200
Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors 199
Acute onset of seeming IDDM in an AIDS patient 199
Non-coding RNAs: novel players in insulin resistance and related diseases 197
Assay for cytoplasmic islet cell antibodies using two-color immunofluorescence and rat pancreas 197
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapy on bone metabolism 197
Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. 197
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 195
Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset 192
The essential role of microRNAs in Diabetes Mellitus: regulators of β cell function and potential disease biomarkers 192
La prevenzione del diabete mellito di tipo 1 191
Impaired caspase-3 expression by peripheral T cells in chronic autoimmune thyroiditis and in autoimmune polyendocrine syndrome-2. 191
A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes 190
Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes 190
Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells 190
MicroRNA circolanti come biomarcatori per il diabete mellito di tipo 2: avanzamenti e prospettive future 189
Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. 189
Circulating microRNAs signature for predicting response to GLP1-RA therapy in Type 2 diabetic patients: a pilot study 187
Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors 187
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial 187
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 187
Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes 186
Incretin Hormones and Beta-cell mass expansion: what we know and what is missing? 185
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies. 183
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010" 183
Viral Infections and diabetes 183
Totale 24.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.423
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.054 0 0 0 0 0 0 0 0 0 372 344 338
2021/20223.296 260 556 209 289 117 101 173 105 145 317 320 704
2022/20234.482 282 318 472 645 475 929 66 353 474 165 192 111
2023/20243.121 149 109 245 133 160 843 967 99 25 124 39 228
2024/20256.875 133 387 620 430 741 347 219 467 659 329 675 1.868
2025/202614.751 1.262 2.233 2.626 1.549 2.531 623 1.702 695 743 787 0 0
Totale 50.099